Scenario analyses assessing the impact of varying costs and false-positive rates in the standard care alternative on the cost-effectiveness estimates
| Variable | Incremental cost per patient screened, $* | Incremental cost per additional case of MINS detected, $* |
|---|---|---|
| Reference case | 112.18 | 1632.51 |
| 25% cost increase in monitoring and 25% cost reduction in standard care alternative (worst case) | 146.81 | 2137.70 |
| 25% cost reduction in monitoring and 25% cost increase in standard care alternative (best case) | 77.88 | 1134.28 |
| 50% of patients with elevated troponin T levels undergo echocardiography | 102.74 | 1495.28 |
| 75% of patients with elevated troponin T levels undergo echocardiography | 107.38 | 1564.85 |
| 0% false-positive in standard care | 112.58 | 1639.39 |
| 0.59% false-positive with monitoring | 113.58 | 1650.16 |
MINS = myocardial injury after noncardiac surgery.
↵* 2015 Canadian dollars.